SEC Form D private-offering filing

Thrombolex, Inc.

Name: Thrombolex, Inc. - new SEC Form D private-offering filing, Kingston, NJ
Published: 2026-03-12

A new SEC Form D private-offering notice from Kingston, NJ, a $51,105,000 filer-stated offering target in Biotech. The source filing is one click away.

Thrombolex, Inc. site↗ Verified via SEC Form D

Medical device company that makes FDA cleared BASHIR endovascular catheters for single session treatment of pulmonary embolism and venous thromboembolic conditions

Filed 2026-03-12Filed to raise $51,105,000First money in 2026-02-26Raised so far $32,775,000HQ (as filed) Kingston, NJSector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified thrombolex.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in New Jersey →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.